Aqilion presents new results from the AQ312 program (oral Ahr agonist) during UEG Week in Vienna October 14, 2024
Lundbeck presents results from two studies in Multiple System Atrophy at International Congress of Parkinson’s Disease and Movement Disorders September 27, 2024
Telia Company announces financial outlook for 2025 and mid-term ambitions, and presents updated strategic priorities at today’s Investor update September 26, 2024
